273 related articles for article (PubMed ID: 10870849)
1. Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients.
Pai GS; Khan M; Barbosa E; Key LL; Craver JR; Curé JK; Betros R; Singh I
Mol Genet Metab; 2000 Apr; 69(4):312-22. PubMed ID: 10870849
[TBL] [Abstract][Full Text] [Related]
2. [X-linked adrenoleukodystrophy].
Aubourg P
Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
McGuinness MC; Zhang HP; Smith KD
Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
[TBL] [Abstract][Full Text] [Related]
4. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
[TBL] [Abstract][Full Text] [Related]
5. Therapy for X-adrenoleukodystrophy: normalization of very long chain fatty acids and inhibition of induction of cytokines by cAMP.
Pahan K; Khan M; Singh I
J Lipid Res; 1998 May; 39(5):1091-100. PubMed ID: 9610777
[TBL] [Abstract][Full Text] [Related]
6. Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts.
Uto T; Contreras MA; Gilg AG; Singh I
Dev Neurosci; 2008; 30(6):410-8. PubMed ID: 19127062
[TBL] [Abstract][Full Text] [Related]
7. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy.
Singh I; Pahan K; Khan M
FEBS Lett; 1998 Apr; 426(3):342-6. PubMed ID: 9600263
[TBL] [Abstract][Full Text] [Related]
9. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy.
Khan M; Pahan K; Singh AK; Singh I
J Neurochem; 1998 Jul; 71(1):78-87. PubMed ID: 9648853
[TBL] [Abstract][Full Text] [Related]
10. Therapy of X-linked adrenoleukodystrophy.
Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
[TBL] [Abstract][Full Text] [Related]
11. Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect.
Deon M; Garcia MP; Sitta A; Barschak AG; Coelho DM; Schimit GO; Pigatto M; Jardim LB; Wajner M; Giugliani R; Vargas CR
Metab Brain Dis; 2008 Mar; 23(1):43-9. PubMed ID: 18026827
[TBL] [Abstract][Full Text] [Related]
12. X-linked adrenoleukodystrophy and primary adrenal insufficiency.
Cappa M; Todisco T; Bizzarri C
Front Endocrinol (Lausanne); 2023; 14():1309053. PubMed ID: 38034003
[TBL] [Abstract][Full Text] [Related]
13. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy.
Lazo O; Contreras M; Hashmi M; Stanley W; Irazu C; Singh I
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7647-51. PubMed ID: 3174658
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin for X-linked adrenoleukodystrophy.
Singh I; Khan M; Key L; Pai S
N Engl J Med; 1998 Sep; 339(10):702-3. PubMed ID: 9729143
[No Abstract] [Full Text] [Related]
15. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients.
Laureti S; Casucci G; Santeusanio F; Angeletti G; Aubourg P; Brunetti P
J Clin Endocrinol Metab; 1996 Feb; 81(2):470-4. PubMed ID: 8636252
[TBL] [Abstract][Full Text] [Related]
16. Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible?
Cappa M; Bizzarri C; Giannone G; Aiello C; Di Biase A
J Endocrinol Invest; 2011 Nov; 34(10):753-6. PubMed ID: 21399389
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol-deprivation increases mono-unsaturated very long-chain fatty acids in skin fibroblasts from patients with X-linked adrenoleukodystrophy.
Engelen M; Ofman R; Mooijer PA; Poll-The BT; Wanders RJ; Kemp S
Biochim Biophys Acta; 2008 Mar; 1781(3):105-11. PubMed ID: 18206987
[TBL] [Abstract][Full Text] [Related]
18. [X-linked adrenoleukodystrophy--2 case reports].
Dumić M; Ille J; Plavsić V; Filipović-Grcić B; Vrljicak K; Barisić N; Roscher A
Lijec Vjesn; 1998; 120(1-2):19-23. PubMed ID: 9650481
[TBL] [Abstract][Full Text] [Related]
19. Loss of AMP-activated protein kinase in X-linked adrenoleukodystrophy patient-derived fibroblasts and lymphocytes.
Singh J; Giri S
Biochem Biophys Res Commun; 2014 Feb; 445(1):126-31. PubMed ID: 24491542
[TBL] [Abstract][Full Text] [Related]
20. Lovastatin in X-linked adrenoleukodystrophy.
Engelen M; Ofman R; Dijkgraaf MG; Hijzen M; van der Wardt LA; van Geel BM; de Visser M; Wanders RJ; Poll-The BT; Kemp S
N Engl J Med; 2010 Jan; 362(3):276-7. PubMed ID: 20089986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
